Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Klaribact and Klaricid in healthy volunteers
NCT05340452Completed
- Sponsor
- University of Karachi
- Start
- Jun 2013
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of clarithromycin in bacterial infection, pneumonia, bronchitis and 4 more (2 arms), sponsored by University of Karachi. Primary endpoints: maximum plasma concentration, Time to reach maximum plasma concentration and 1 more. Started Jun 2013; status: completed.
02
Drugs
clarithromycin
03
Conditions
bacterial infectionpneumoniabronchitisskin and soft tissue infections (SSTIs)Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05340452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05340452.